Cell Bio Human Tech Co.,Ltd (KOSDAQ:318160)
South Korea flag South Korea · Delayed Price · Currency is KRW
6,980.00
-210.00 (-2.92%)
At close: Sep 16, 2026

KOSDAQ:318160 Balance Sheet

Millions KRW. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
11,00515,9173,0994,0524,49513,929
Short-Term Investments
907.6668411,2079,4332,4007,463
Cash & Short-Term Investments
11,91216,60114,30613,4856,89521,392
Cash Growth
53.54%16.04%6.09%95.59%-67.77%69.12%
Accounts Receivable
13,27010,8564,0144,2413,0723,584
Other Receivables
310.4263.834.9696.4932.52154.82
Receivables
13,59010,9204,0494,3373,1043,739
Inventory
14,93913,8584,5508,2819,1066,254
Prepaid Expenses
54.64756.24459.29308.51281.8555.4
Other Current Assets
1,4571,885628.87506.67548.41630.85
Total Current Assets
41,95344,02123,99226,91819,93632,071
Property, Plant & Equipment
42,93835,49324,56822,76423,15223,904
Long-Term Investments
2,5384,6311,034644.17548.66509.54
Other Intangible Assets
1,9131,4471,2551,282818.32817.77
Long-Term Accounts Receivable
00----
Long-Term Deferred Tax Assets
-503.92457.97557.14825.57248.83
Other Long-Term Assets
2,6642,3621,5971,030701.66517.12
Total Assets
92,00688,45852,90553,19645,98258,069

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
1,9122,984837.061,048861.031,953
Accrued Expenses
1,6491,782600.95564.82709.24414.39
Short-Term Debt
7,23710,5063,6755,8754,9424,735
Current Portion of Long-Term Debt
764.81604.58----
Current Portion of Leases
253.62209.51217.9529.73220.38233.33
Current Income Taxes Payable
503.66241.2462.79540.81573.61,449
Other Current Liabilities
2,3152,870490499.72441.35833.07
Total Current Liabilities
14,63619,1976,2848,5597,7489,617
Long-Term Debt
12,4218,907---9,421
Long-Term Leases
302.54282.77174.5621.8968.78274.54
Pension & Post-Retirement Benefits
454.27451----
Long-Term Deferred Tax Liabilities
550.37550.37----
Other Long-Term Liabilities
60.0365.8134.8453.0760.3429.76
Total Liabilities
28,42529,4556,4938,6347,87719,342

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
4,6694,6714,6304,6304,1004,100
Additional Paid-In Capital
27,59227,59223,83523,83518,07718,077
Retained Earnings
31,55726,71617,99513,61621,08631,294
Treasury Stock
-4,824-4,074-2,833-37.25-7,916-7,916
Comprehensive Income & Other
1,9591,3912,3382,072-3,648-17,136
Total Common Equity
60,95256,29645,96544,11631,70028,420
Minority Interest
2,1822,261----
Shareholders' Equity
63,58159,00346,41244,56338,10538,726
Total Liabilities & Equity
92,00688,45852,90553,19645,98258,069

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
20,98020,5104,0685,9275,23214,663
Net Cash (Debt)
-9,067-3,90910,2387,5581,6636,728
Net Cash Growth
--35.46%354.48%-75.28%-43.71%
Net Cash Per Share
-1091.80-476.291147.60894.55237.54852.31
Filing Date Shares Outstanding
8.368.388.549.2677
Total Common Shares Outstanding
8.368.388.549.2677
Working Capital
27,31724,82317,70918,35912,18722,454
Book Value Per Share
7292.696721.255383.594765.584527.974059.42
Tangible Book Value
59,03954,84944,71042,83430,88227,602
Tangible Book Value Per Share
7063.786548.535236.554627.084411.093942.62
Land
-6,7572,3602,3602,3602,360
Buildings
-11,5958,9868,4428,4598,282
Machinery
-15,82311,56510,28710,74210,622
Construction In Progress
-234.69766.68128.0730.27310.99